Abeona Therapeutics Inc.
ABEO
$5.56
$0.030.54%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -41.95% | -120.17% | 82.95% | 1,369.52% | 61.91% |
| Total Depreciation and Amortization | 6.63% | 40.72% | 22.99% | 12.12% | 12.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 43.12% | 147.74% | -99.37% | -520.24% | -119.68% |
| Change in Net Operating Assets | 57.45% | 84.54% | -9,464.61% | 539.42% | -21.48% |
| Cash from Operations | -7.62% | -8.42% | -73.18% | -48.09% | -26.58% |
| Capital Expenditure | 33.26% | -90.26% | -523.76% | -308.02% | -93.24% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.06% | -45.04% | -977.69% | 465.54% | 179.16% |
| Cash from Investing | 17.80% | -49.39% | -947.95% | 453.23% | 153.90% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -34.45% | -- | -85.75% | 5.95% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | 100.00% | 57.14% | 96.83% |
| Cash from Financing | -132.83% | -31.99% | 1,826.76% | -85.76% | -73.40% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -129.93% | -162.70% | -331.29% | 775.02% | -340.55% |